SCOPUS 정보 검색 플랫폼

Drug Safety

Volumn 32, Issue 11, 2009, Pages 1097-1100

Attention-deficit hyperactivity disorder (ADHD) treatment and sudden death

(1) Besag, Frank M C a

a Bedfordshire and Luton Partnership NHS Trust ^* (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; COMORBIDITY; DATA BASE; DISEASE PREDISPOSITION; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HUMAN; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZED MORTALITY RATIO; SUDDEN DEATH; SUICIDE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEATH, SUDDEN; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 70349970174 PISSN: 01145916 EISSN: 11791942 Source Type: Journal
DOI: 10.2165/11530340-000000000-00000 Document Type: Note

Times cited : (4)

References (13)

1
- 33645507718
- ADHD drugs and cardiovascular risk
- Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354 (14): 1445-1448
- (2006) N Engl J Med , vol.354 , Issue.14 , pp. 1445-1448
- Nissen, S.E.¹

2
- 33646860996
- ADHD drugs and cardiovascular risk [comment]
- Anders T, Sharfstein S. ADHD drugs and cardiovascular risk [comment]. N Engl J Med 2006; 354 (21): 2296-2298
- (2006) N Engl J Med , vol.354 , Issue.21 , pp. 2296-2298
- Anders, T.¹ Sharfstein, S.²

3
- 33646860996
- ADHD drugs and cardiovascular risk [comment]
- Rappley MD, Moore JW, Dokken D. ADHD drugs and cardiovascular risk [comment]. N Engl J Med 2006; 354 (21): 2296-2298
- (2006) N Engl J Med , vol.354 , Issue.21 , pp. 2296-2298
- Rappley, M.D.¹ Moore, J.W.² Dokken, D.³

4
- 33749072081
- Stimulants and sudden death: What is a physician to do?
- Wilens TE, Prince JB, Spencer TJ, et al. Stimulants and sudden death: what is a physician to do? Pediatrics 2006; 118 (3): 1215-1219
- (2006) Pediatrics , vol.118 , Issue.3 , pp. 1215-1219
- Wilens, T.E.¹ Prince, J.B.² Spencer, T.J.³ Al, E.⁴

5
- 70349943574
- 166/9/992 [Accessed 2009 Aug 28]
- Gould MS, Walsh T, Munfakh JL, et al. Sudden death and use of stimulant medications in youths [online]. Available from URL: http://ajp.psychiatryonline. org/cgi/reprint/ajp; 166/9/992 [Accessed 2009 Aug 28]
- Sudden Death and Use of Stimulant Medications in Youths [Online]
- Gould, M.S.¹ Walsh, T.² Munfakh, J.L.³ Al, E.⁴

6
- 84873028033
- US FDA Accessed 2009 Aug 28
- US FDA. Communication about an ongoing safety review of stimulant medications used in children with attention-deficit/hyperactivity disorder (ADHD) [online]. Available from URL: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm165858.htm [Accessed 2009 Aug 28]
- Communication about An Ongoing Safety Review of Stimulant Medications Used in Children with Attention-deficit/hyperactivity Disorder (ADHD) [Online]

7
- 70349976442
- Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: A retrospective cohort study of children, adolescents and young adults using the General Practice Research Database
- McCarthy S, Cranswick N, Potts L, et al. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the General Practice Research Database. Drug Saf 2009; 32 (11): 1089-1096
- (2009) Drug Saf , vol.32 , Issue.11 , pp. 1089-1096
- McCarthy, S.¹ Cranswick, N.² Potts, L.³

8
- 26444480727
- Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin
- George AK, Kunwar AR, Awasthi A. Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. J Child Adolesc Psychopharmacol 2005; 15 (4): 693-695
- (2005) J Child Adolesc Psychopharmacol , vol.15 , Issue.4 , pp. 693-695
- George, A.K.¹ Kunwar, A.R.² Awasthi, A.³

9
- 22444433119
- Myocardial in-farction in an adolescent taking Adderall
- Gandhi PJ, Ezeala GU, Luyen TT, et al. Myocardial in-farction in an adolescent taking Adderall. Am J Health Syst Pharm 2005; 62 (14): 1494-1497
- (2005) Am J Health Syst Pharm , vol.62 , Issue.14 , pp. 1494-1497
- Gandhi, P.J.¹ Ezeala, G.U.² Luyen, T.T.³

10
- 0141497553
- Depression in epilepsy: Prevalence, clinical semiology, pathogenic mechanisms, and treatment
- Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003; 54 (3): 388-398
- (2003) Biol Psychiatry , vol.54 , Issue.3 , pp. 388-398
- Kanner, A.M.¹

11
- 66749089427
- Attention-deficit-hyperactivity disorder: An update
- Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 2009; 29 (6): 656-679
- (2009) Pharmacotherapy , vol.29 , Issue.6 , pp. 656-679
- Dopheide, J.A.¹ Pliszka, S.R.²

12
- 0037227127
- Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
- Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111 (1): 179-185
- (2003) Pediatrics , vol.111 , Issue.1 , pp. 179-185
- Wilens, T.E.¹ Faraone, S.V.² Biederman, J.³

13
- 43949133846
- Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? [comment]
- Volkow ND, Swanson JM. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? [comment]. Am J Psychiatry 2008; 165 (5): 553-555
- (2008) Am J Psychiatry , vol.165 , Issue.5 , pp. 553-555
- Volkow, N.D.¹ Swanson, J.M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.